ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
28.515
-0.135
(-0.47%)
Cerrado 25 Enero 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

AQWA Noticias

Solo noticias oficiales
Se encontraron 0 artículos
maddyandboomer maddyandboomer 3 minutos hace
Need a good honest company first before getting what you call good investors....and axxa ain't it....they have shown their colors and resembles red flags...not green $ signs
AXXA
Fire_starter Fire_starter 3 minutos hace
🔥🔥🔥500 BILLION FOR THE CURE TO CANCER M-RNA VACCINE🔥🔥🔥
RNAZ
Smartypants2 Smartypants2 4 minutos hace
If jurisdiction was an issue, XTI's lawyers would have brought it as a reason for dismissal previously. Maybe they did -- and the judge already ruled against them. Either way, it's very doubtful it's still an issue in this case.
XERI
jsc52033 jsc52033 4 minutos hace
but you follow the penny stocks why
BMXI
IcyGalaxy60 IcyGalaxy60 4 minutos hace
What about 500k down payement for mt.Vernon?
NBRI
gitreal gitreal 5 minutos hace
I don't invest in scams.
BMXI
doc2016 doc2016 5 minutos hace
me:



the ban on outgoing messaging from federal agencies should surprise no one. the new administration won this cycle by emphasizing it was time for changes in defense to state to homeland security to treasury to healthcare.meta and data; meta data.
of course
NVDA
jour_trader jour_trader 5 minutos hace
I believe there is an authorized generic for OxyContin, but that's not quite the same. Once generics are approved the market price will tank, just like Vyvanse will. If Elite were the only one to get the approval that is one thing, but it is not the case. Buying Elite would not stop OxyContin pricin
ELTP
mmayr mmayr 5 minutos hace
Charlie Rich * Rollin' with the Flow 1977 HQ

[yt]b9_7ByKnwWY[/yt]

https://www.youtube.com/watch?v=b9_7ByKnwWY
StockItOut StockItOut 6 minutos hace
You're wrong. That's why you hide behind "probably."
XERI
north40000 north40000 6 minutos hace
Good idea, moms. We have both MNMD and PFE in our portfolios. PFE's expensive acquisition of SGEN(very profitable for us) has been slow to bring enough revenue to the balance sheet to solve PFE's problem being termed a laggard in pharma-land. HLS in Canada terminated a contract with PFE that involve
AMRN MNMD PFE
Ms Labonte Ms Labonte 7 minutos hace
Next leg up wide open $weet$$
WEET
getmoreshares getmoreshares 7 minutos hace
Good Afternoon-- catching up on the posts!
Smartypants2 Smartypants2 7 minutos hace
You don't even know the difference between "knew" and "new," I knew it!
XERI
Monksdream Monksdream 8 minutos hace
RAIL
https://investorshub.advfn.com/uimage/uploads/2025/1/25/zlxqsIMG_4814.gif
RAIL
misterfishman misterfishman 8 minutos hace
Be careful the bird like sitting on high voltage lines lol.
IGPK
Steady_T Steady_T 8 minutos hace
Selection issues for an OLE are many.

There are the drop outs from the original trial. That selects against those who can not tolerate the drug or the titration rate.
There are those that don't choose to go into the OLE for whatever reason. That is self selection.
There
AVXL
Smartypants2 Smartypants2 8 minutos hace
Once again, you are absolutely incorrect. But at least you are consistent.
XERI
MEPinvest MEPinvest 8 minutos hace
Do you interpret that as a good thing or a bad thing? Do you think they're being ominous and distressful to investors or cooking up something good for all?
CRTG
misterfishman misterfishman 9 minutos hace
I hope so. Sometime this year.
IGPK
jsc52033 jsc52033 10 minutos hace
are you actualy invest in BMXI or is this just boad you can talk on
BMXI
juicyjuice10002 juicyjuice10002 10 minutos hace
The financial advisor was advised by the insider to buy the shares but that conversation was kept secret. Insider advising the financial advisor is more likely.
FNMA
3331 3331 10 minutos hace
BIEL: VAGUS NERVE PATENT (PENDING)
NY Post - Jan. 23, 2025
Implantable vagus nerve stimulation (VNS) devices, which can cost $50,000, have long been used to treat epilepsy, depression and stroke. That’s because jolting the vagus nerve — the longest cranial nerve in the body — can help
Monksdream Monksdream 10 minutos hace
MESO
https://investorshub.advfn.com/uimage/uploads/2025/1/25/rkzrzIMG_4813.gif
MESO

Su Consulta Reciente

Delayed Upgrade Clock